The rise of Viagra and its influence on the drug landscape presents a complex question for shareholders. While the early sales data were impressive, the exclusivity has lapsed, leading to a deluge of off-brand https://matheagqt170674.blog2news.com/41906240/the-blue-pill-and-the-pharmaceutical-industry-a-speculative-bet